These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 23652625)

  • 1. The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
    Hultman K; Strickland S; Norris EH
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1251-8. PubMed ID: 23652625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
    Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
    J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
    Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease.
    Mann DMA; Davidson YS; Robinson AC; Allen N; Hashimoto T; Richardson A; Jones M; Snowden JS; Pendleton N; Potier MC; Laquerrière A; Prasher V; Iwatsubo T; Strydom A
    Acta Neuropathol; 2018 Oct; 136(4):569-587. PubMed ID: 29770843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
    Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
    Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
    Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APOE-ε2 and APOE-ε4 correlate with increased amyloid accumulation in cerebral vasculature.
    Nelson PT; Pious NM; Jicha GA; Wilcock DM; Fardo DW; Estus S; Rebeck GW
    J Neuropathol Exp Neurol; 2013 Jul; 72(7):708-15. PubMed ID: 23771217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.
    Garcia-Segura ME; Fischer CE; Schweizer TA; Munoz DG
    J Alzheimers Dis; 2019; 72(4):1077-1087. PubMed ID: 31744003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
    Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
    JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice.
    Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE
    J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy.
    van Helmond Z; Miners JS; Kehoe PG; Love S
    Brain Pathol; 2010 Mar; 20(2):468-80. PubMed ID: 19725829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+).
    Mäkelä M; Paetau A; Polvikoski T; Myllykangas L; Tanskanen M
    J Alzheimers Dis; 2016; 49(1):149-57. PubMed ID: 26444758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
    de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
    J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
    Cho HS; Hyman BT; Greenberg SM; Rebeck GW
    J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.